<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80" class="ref">
 <label class="label">80</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Xie</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wong</surname>
    <given-names class="given-names">C. C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cheng</surname>
    <given-names class="given-names">K. W.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Huang</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Constantinides</surname>
    <given-names class="given-names">P. P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rigas</surname>
    <given-names class="given-names">B.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety</article-title>
  <source class="source">
   <italic class="italic">British Journal of Pharmacology</italic>
  </source>
  <year class="year">2012</year>
  <volume class="volume">167</volume>
  <issue class="issue">1</issue>
  <fpage class="fpage">222</fpage>
  <lpage class="lpage">232</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1111/j.1476-5381.2012.01982.x</pub-id>
  <pub-id pub-id-type="other" class="pub-id">2-s2.0-84864713877</pub-id>
  <?supplied-pmid 22489789?>
  <pub-id pub-id-type="pmid" class="pub-id">22489789</pub-id>
 </element-citation>
</ref>
